Zevra Therapeutics, Inc.
NASDAQ: ZVRA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Neil F. McFarlane
- Employees
- 59
- Headquarters
- Celebration, United States
- IPO year
- 2015
- Market cap
- $773.2M
- Website
- https://zevra.com
Loading ZVRA…
Loading profile data…Frequently asked questions about ZVRA
What does Zevra Therapeutics, Inc. (ZVRA) do?
Zevra Therapeutics, Inc., founded in 2006 and based in Celebration, Florida, is a biopharmaceutical company dedicated to discovering and developing innovative treatments for rare diseases. The company employs its proprietary Ligand Activated Therapy (LAT) technology to create novel prodrug versions of existing FDA-approved medications or to enab...
Where does ZVRA trade?
Zevra Therapeutics, Inc. (ZVRA) trades on the NASDAQ Global Select.
What sector is ZVRA in?
Zevra Therapeutics, Inc. (ZVRA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Zevra Therapeutics, Inc.?
Neil F. McFarlane is the chief executive officer of Zevra Therapeutics, Inc. (ZVRA).
Where is Zevra Therapeutics, Inc. headquartered?
Zevra Therapeutics, Inc. is headquartered in United States.
Does ZVRA pay a dividend?
Zevra Therapeutics, Inc. (ZVRA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ZVRA go public?
Zevra Therapeutics, Inc. (ZVRA) completed its initial public offering in 2015.